Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7629287 | 0.95 | TSHR (0.50) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL396695 | 0.88 | THRB (0.46) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL4968609 | 0.87 | TSHR (0.43) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL4444766 | 0.86 | TSHR (0.51) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL35127 | 0.81 | TSHR (0.58) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL5575634 | 0.81 | TSHR (0.46) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL10793367 | 0.81 | TSHR (0.49) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1293374 | 0.81 | TSHR (0.49) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL16486229 | 0.81 | TSHR (0.53) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL5832458 | 0.80 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10604658-B2 | Organic silicon compound, surface treatment agent containing same, resin composition containing same, and gel or cured product of same | DOW TORAY CO., LTD. (JP) | 2020-03-31 | — | — | US | disclosed |
| WO-2015022998-A1 | NOVEL ORGANIC SILICON COMPOUND, SURFACE TREATMENT AGENT CONTAINING SAME, RESIN COMPOSITION CONTAINING SAME, AND GEL OR CURED PRODUCT OF SAME | DOW CORNING TORAY CO., LTD. (JP) | 2015-02-19 | — | — | WO | disclosed |
| US-8168371-B2 | Positive photosensitive resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-01 | — | — | US | disclosed |
| EP-2109001-B1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION | NISSAN CHEMICAL IND LTD (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20100028805-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2109001-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION | Nissan Chemical Industries, Ltd. (JP) | 2009-10-14 | — | — | EP | disclosed |
| EP-1354898-B1 | MONOMER COMPOSITION, POLYMER OBTAINED THEREFROM, AND OCULAR LENS | JOHNSON & JOHNSON VISION CARE (US) | 2006-04-26 | — | — | EP | disclosed |
| US-20060012750-A1 | Monomer composition and polysmers and ophthalmic lenses in which it is used | JOHNSON & JOHNSON VISION CARE, INC. | 2006-01-19 | — | — | US | disclosed |
| EP-1354898-A1 | MONOMER COMPOSITION, POLYMER OBTAINED THEREFROM, AND OCULAR LENS | Johnson & Johnson Vision Care, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| US-5153091-A | Development of magnetic latent images using toner containing encapsulated polylauryl methacrylate/magnetite core and polyurea shell blended with non-encapsulated polybutyl methacrylate-styrene copolymer/magnetite | XEROX CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| US-5023159-A | Encapsulated electrophotographic toner compositions | XEROX CORPORATION (US) | 1991-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10604658-B2 | Organic silicon compound, surface treatment agent containing same, resin composition containing same, and gel or cured product of same | ASH2L, RPS7, MRPS27 | TSHR 3888/4885POLB 2037/4885APEX1 3050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.